As microglia treated by IFNγ and TNFα supposedly represent a population of M1 activated microglia and TGFβ1 treated cells a subpopulation of M2 activated microglia, the tumor cells in our experimental system seem to shift microglia towards a more M2-like phenotype [31]. The gene discussed is IFNG; the disease is neoplasm.